When to Recheck CT for Non-Occlusive PE
Routine follow-up CT imaging is not recommended for asymptomatic patients with non-occlusive PE; repeat imaging should only be performed if new or persistent symptoms develop, or if there are specific risk factors for chronic thromboembolic pulmonary hypertension (CTEPH).
Primary Recommendation
The 2019 ESC guidelines explicitly state that follow-up imaging is not routinely recommended in asymptomatic patients after acute PE 1. This applies directly to non-occlusive PE cases where patients are clinically stable and responding appropriately to anticoagulation.
When Repeat CT IS Indicated
Repeat CT pulmonary angiography should be considered in these specific scenarios:
1. New or Persistent Symptoms
- Persistent or new-onset dyspnea after the acute phase
- Functional limitation that develops or fails to resolve
- Unexplained clinical deterioration while on anticoagulation 1
Recent data shows that repeat CTPA identifies PE in 34.4% of cases when performed for clinical concern, compared to only 14.3% on initial scans, supporting symptom-driven repeat imaging 2.
2. Risk Factors for CTEPH
Implement staged diagnostic workup including repeat imaging if the patient has:
- Risk factors for development of chronic thromboembolic disease
- Symptoms suggesting CTEPH (progressive dyspnea, exercise intolerance) 1
3. Suspected Recurrent PE
- New clinical presentation suggesting recurrent thromboembolism
- High-risk patients (cancer, prior VTE history, elevated Wells score) who develop new symptoms 2
Clinical Pitfalls to Avoid
Do Not Order Routine Follow-Up Scans
The evidence is clear that asymptomatic patients should not undergo routine surveillance imaging. This practice:
- Exposes patients to unnecessary radiation (particularly concerning in young women) 3
- Doubles cumulative radiation dose (272 vs 121 mGy·cm) 4
- Has low diagnostic yield without clinical indication
Beware of False-Positive Incidental Findings
When non-occlusive PE is found incidentally on non-dedicated CT protocols:
- 48% may be false-positives requiring confirmatory CTPA 5
- Consider expert radiologist review before ordering confirmatory CTPA, especially for intermediate-certainty findings (grade 3) 5
- Expert review has 96% agreement with ground-truth CTPA and can reduce unnecessary repeat imaging 5
Follow-Up Strategy Instead of Routine Imaging
Rather than routine CT, the ESC recommends 1:
- Clinical follow-up at regular intervals (e.g., yearly after initial 3-6 months)
- Symptom surveillance: Ask specifically about dyspnea and functional limitation
- Risk reassessment for VTE recurrence, bleeding on anticoagulation, and occult malignancy
- Anticoagulation duration decisions at 3-6 months based on clinical factors, not imaging
Special Consideration: High-Risk Populations
Patients with cancer, prior VTE, or elevated clinical risk scores who undergo repeat evaluation have higher PE detection rates (positive predictive value of D-dimer increases from 19.3% to 38.2% on repeat visits) 2. However, even in these patients, repeat imaging should be symptom-driven, not routine.
The 2026 AHA/ACC guidelines support this approach by emphasizing risk-stratified management and clinical assessment over routine imaging surveillance 6.